Black Rock Inc. Pear Therapeutics, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.21 - $1.24 $20,633 - $121,833	-98,253 Reduced 2.84%	3,358,886 $873,000
Q4 2022 Feb 13, 2023	BUY	$0.99 - $2.91 $437,826 - $1.29 Million	442,249 Added 14.67%	3,457,139 $4.08 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $2.27 $336,196 - $5.87 Million	2,586,124 Added 603.16%	3,014,890 $6.15 Million
Q2 2022 Aug 12, 2022	BUY	$1.54 - $6.48 $19,231 - $80,922	12,488 Added 3.0%	428,766 $660,000
Q1 2022 May 12, 2022	BUY	$3.67 - $7.63 $1.53 Million - $3.18 Million	416,278 New	416,278 $2.1 Million

23M

Ticker PEAR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 138,768,992
Market Cap $1.39M
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.